We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 2,546

Federal Court declares omeprazole formulation patent valid and infringed

  • Norton Rose Fulbright Canada LLP
  • -
  • Canada
  • -
  • March 25 2015

On March 16, 2015, Justice Barnes of the Federal Court issued his decision in AstraZeneca Canada Inc. et al v. Apotex Inc., 2015 FC 322, declaring

IP Australia releases medical device innovation report

  • Phillips Ormonde Fitzpatrick
  • -
  • Australia
  • -
  • March 24 2015

The study identified 139,170 Patent Cooperation Treaty (PCT) applications filed globally in the medical devices area with a priority date between

Zarxio’s approval: some insights and unanswered questions regarding the future of U.S. biosimilars

  • Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • -
  • USA
  • -
  • March 24 2015

On March 6, 2015, more than five years after the passage of the Biologics Price Competition and Innovation Act of 2009 (BPCIA), the U.S. Food and

Judge finds biosimilar patent procedures optional

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • March 23 2015

Judge Seeborg of the U.S. District Court for the Northern District of California issued an order inAmgen, Inc. v. Sandoz, Inc., ruling that the

One more hurdle cleared Amgen’s preliminary injunction motion for filgrastim is denied

  • Sterne Kessler Goldstein & Fox
  • -
  • USA
  • -
  • March 23 2015

On March 19, 2015, Judge Seeborg of the United States District Court for the Northern District of California denied Amgen Inc.'s motion for a

CIPO updates guidance on medical use claims

  • Bereskin & Parr LLP
  • -
  • Canada
  • -
  • March 23 2015

On March 18, 2015 the Canadian Intellectual Property Office issued a practice notice containing revised examination practice guidelines pertaining to

Draeger Medical Systems files for Declaratory Judgment against My Health

  • Knobbe Martens Olson & Bear LLP
  • -
  • USA
  • -
  • March 23 2015

On March 19, 2015, Draeger Medical Systems, Inc. ("Draeger") filed a Declaratory Judgment action against My Health, Inc. ("My Health"). The complaint

CIPO issues revised examination guidance on methods of medical treatment and dosage regimens

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • March 20 2015

The Canadian Intellectual Property Office (CIPO) has now released Practice Notice PN 2015-01, which relates to examination of medical treatment

New Patent Office guidance on medical use claims

  • Smart & Biggar/Fetherstonhaugh
  • -
  • Canada
  • -
  • March 20 2015

The Canadian Intellectual Property Office has released revised guidance on examination of medical use claims: PN 2015-01 "Revised Examination

District Court rules against Amgen’s motion for preliminary injunction to prevent marketing of Sandoz’s biosimilar Zarxio

  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • -
  • USA
  • -
  • March 20 2015

In an order released on March 19, 2015, U.S. District Court Judge Richard Seeborg of the Northern District of California denied Amgen’s motion for